IDiyas

For the Inventor, By the Inventor

Brier, WA, United States of America

John M Reno

USPTO Granted Patents = 45 

 

Average Co-Inventor Count = 3.3

ph-index = 22

Forward Citations = 2,927(Granted Patents)


Location History:

  • Lynnwood, WA (US) (1989)
  • Brier, WA (US) (1990 - 2010)

Company Filing History:

goldMedal36 out of 156 
 
Neorx Corporation
 patents
silverMedal2 out of 3 
 
Aletheon Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 1 
 
Noerx Corporation
 patent
4. 1 out of 1,831 
 
Scimed Life Systems, Inc.
 patents
5. 1 out of 2 
 
University of Wa
 patents
6. 1 out of 7,680 
 
The Dow Chemical Company
 patents
7. 1 out of 3 
 
Kaleidos Pharma, Inc.
 patents
8. 1 out of 14 
 
Poniard Pharmaceuticals, Inc.
 patents
9. 2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1989-2010

Loading Chart...
Loading Chart...
45 patents (USPTO):
1. 7744853 - Radiolabeled annexins (2010-06-29),
2. 7144991 - Streptavidin expressed gene fusions and methods of use thereof (2006-12-05),
3. 7115248 - Radiolabeled annexins (2006-10-03),
4. 7078013 - Pretargeting methods and compounds (2006-07-18),
5. 6720350 - Therapeutic inhibitor of vascular smooth muscle cells (2004-04-13),
6. 6709652 - Pretargeting methods and compounds (2004-03-23),
7. 6677307 - TGF-&agr; polypeptides, functional fragments and methods of use therefor (2004-01-13),
8. 6663881 - Therapeutic inhibitor of vascular smooth muscle cells (2003-12-16),
9. 6569441 - Therapeutic inhibitor of vascular smooth muscle cells (2003-05-27),
10. 6491938 - Therapeutic inhibitor of vascular smooth muscle cells (2002-12-10),
11. 6416738 - Pretargeting methods and compounds (2002-07-09),
12. 6358989 - Therapeutic inhibitor of vascular smooth muscle cells (2002-03-19),
13. 6358710 - Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 (2002-03-19),
14. 6358490 - Three-step pretargeting methods and compounds (2002-03-19),
15. 6306421 - Therapeutic inhibitor of vascular smooth muscle cells (2001-10-23),

Title: Unveiling the Innovations of John M Reno

Introduction:

Meet John M Reno, a prolific inventor based in Brier, WA, US, with an impressive track record of 45 patents under his belt.

Latest Patents:

1. Radiolabeled annexins: John M Reno's innovation focuses on radiolabeled annexins and modified annexin conjugates used for imaging vascular thrombi. The methods for creating and utilizing these radiolabeled annexin conjugates are also elucidated.

2. Streptavidin expressed gene fusions: His recent invention delves into vectors designed for expressing genomic streptavidin fusion cassettes. These vectors produce fusion proteins, including a single-chain antibody and genomic streptavidin, with various applications such as diagnostic markers and cell-specific targeting agents.

Career Highlights:

John M Reno has contributed his inventive prowess to renowned companies such as Neorx Corporation and Aletheon Pharmaceuticals, Inc.

Collaborations:

During his tenure, John M Reno collaborated with notable individuals like Louis J Theodore and Linda M Gustavson, fostering a culture of innovation and excellence.

Conclusion:

In conclusion, John M Reno stands as a testament to ingenuity and creativity in the realm of inventions. His groundbreaking work in radiolabeled annexins and streptavidin expressed gene fusions reflects his dedication to pushing the boundaries of scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…